Name: In Vivo Gene Delivery into Mouse Mammary Epithelial Cells Through Mammary Intraductal Injection (Video) | JoVE Journal
Uploaded: 2023-02-10T13:00:00.000+00:00
Duration: 5 min 36 s
Description: Learn intraductal injection of viral vectors for gene delivery into mouse mammary epithelial cells. This method enables controlled genetic manipulation to study tumor genesis and breast cancer biology in vivo.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

We thank Dr. Gary Chamness for his helpful comments on this manuscript. This work was supported by the Department of Defense (DOD) CDMRP BC191649 (YL) and BC191646 (YL) as well as the National Institutes of Health (NIH) CA271498 (YL). The authors would like to thank the Breast Center Pathology Core Facility supported by SPORE P50CA186784, and the Cytometry and Cell Sorting Core supported by CPRIT-RP180672, NIH CA125123, and RR024574 with the assistance of Joel M. Sederstrom.

All procedures using mice were performed in compliance with the Institutional Animal Care and Use Committee-approved animal protocol. For the present study, 9-12-week-old FVB/N or MMTV-tva female mice were used. The mice were obtained commercially or self-made (see Table of Materials). The Lenti-EGFP (FUCGW) and RCAS-Erbb2 (Neu) viruses were used. Virus preparation and titer determination were performed following the previously published reports10,12.
1. Syringe preparation
<ol>
	<li>Cut the 33 G metal hub needles (see Table of Materials) to approximately 1 cm in length. Store the needles and the 50 &#181;L syringe in 70% alcohol after autoclaving.</li>
	<li>Take out syringes and needles from the alcohol. Propel the remaining alcohol out of the syringe and needle. Disassemble the syringe for air drying on an autoclaved absorbent bench pad.</li>
	<li>Assemble the syringe after drying.</li>
</ol>
2. Virus preparation
<ol>
	<li>Take out one or several viral stock tubes as needed from the -80 &#730;C freezer and thaw the virus on ice. 
	NOTE: Depending on the number of cells to be infected, the virus may need to be diluted into intended titers using 1x PBS at this time.</li>
	<li>Add bromophenol blue by dipping the pipette tip to a depth of 1 cm into the bromophenol blue powder (see Table of Materials). Then, bring the attached trace amount of bromophenol blue into the virus suspension. 
	NOTE: For the present study, the viral stock is usually 200 &#181;L per tube, so the final dye concentration is approximately 0.2% (0.2 &#181;g/100 &#181;L). Bromophenol blue should be sterilized with microwave radiation for 45 seconds at high power of 1250 W&#160;(see&#160;Table of Materials). Ensure to carry whole procedure in a sterile environment.</li>
	<li>Mix the bromophenol blue with the virus solution by pipetting up and down 10 times.</li>
	<li>Place the virus on ice and bring the ice bucket to the vivarium.</li>
</ol>
3. Animal preparation
<ol>
	<li>Anesthetize a female mouse by intraperitoneal injection of 2 &#181;L/g of anesthetic (37.6 mg/mL ketamine, 1.92 mg/mL xylazine, and 0.38 mg/mL acepromazine, see Table of Materials). Check the depth of anesthesia with a toe pinch. Apply ointment on the eyes to prevent dryness while under anesthesia. 
	NOTE: The mouse must be non-responsive to toe&#160;pinch under good anesthesia. Isoflurane may also be used to anesthetize the mice.</li>
	<li>Put the mouse in a supine position on a warm pad and attach all four limbs to the bench using adhesive tape.</li>
	<li>Identify one nipple (or more) to be injected (number 4 is preferred for the present study). Expose it by trimming the surrounding hair using a pair of scissors.</li>
	<li>Apply&#160;70% alcohol and iodophor swabs to the nipple area in three rounds to&#160;clean and expose the nipple.</li>
</ol>
4. Intraductal injection of virus
NOTE: A magnifying lamp may be used to help visualize the nipple opening.
<ol>
	<li>Transect the distal tip of a nipple using a pair of sterile&#160;microdissection spring scissors, until a small central ductal opening can be seen under a magnifier lamp (see Table of Materials).</li>
	<li>Load 10 &#181;L of virus/bromophenol blue mixture into the syringe. 
	NOTE: Lenti-EGFP (FUCGW) and RCAS-Erbb2 (Neu) are used in this demonstration.</li>
	<li>Carefully insert the needle into the nipple opening with the help of the magnifier lamp. The orientation of the needle is adjusted slightly from medial to lateral to align with the main duct.</li>
	<li>Inject the entire 10 &#181;L of the virus into the duct tree. 
	NOTE: The ducts under the skin should turn blue, if the injection is successful. Any resistance or the appearance of a localized color change indicates the failure of the injection.</li>
	<li>Put the mouse on a slide warmer set at 45 &#176;C until the mouse fully wakes up(~30-60 min).</li>
</ol>
5. Detection of infected cells by a fluorescent stereomicroscope
<ol>
	<li>Three to five days after injection of the virus carrying GFP or other fluorescent genes, euthanize the mouse by over-dosing it with 4 uL/g of anesthetic (37.6 mg/mL ketamine, 1.92 mg/mL xylazine, and 0.38 mg/mL acepromazine).</li>
	<li>Open the thoracic cavity. Cut the skin along the ventral middle line and along the upper and lower limbs using a pair of scissors. Lift the skin and expose the mammary glands.</li>
	<li>Remove the injected mammary gland from the skin using a pair of forceps and scissors. Also, remove an un-injected gland as a control.</li>
	<li>Place the mammary glands on glass slides and spread the glands to their original shape.</li>
	<li>Observe and image the glands under a fluorescent stereomicroscope.</li>
</ol>

<ol><li>Nguyen, D. -A., Beeman, N., Lewis, M., Schaack, J., Neville, M. C. <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=author%3aNguyen%2C+D-A+%22Methods+in+Mammary+Gland+Biology+and+Breast+Cancer+Research.+Eds+Margot%22">Methods in Mammary Gland Biology and Breast Cancer Research. Eds Margot</a>. Ip, M. M., Asch, B. B. , Springer US. 259-270 (2000).</li>
<li>Gordon, J. W., Ruddle, F. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Integration+and+stable+germ+line+transmission+of+genes+injected+into+mouse+pronuclei%5BTitle%5D)+AND+%22Science%22%5BJournal%5D)">Integration and stable germ line transmission of genes injected into mouse pronuclei.</a> Science. 214 (4526), 1244-1246 (1981).</li>
<li>Costantini, F., Lacy, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Introduction+of+a+rabbit+beta-globin+gene+into+the+mouse+germ+line%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">Introduction of a rabbit beta-globin gene into the mouse germ line.</a> Nature. 294 (5836), 92-94 (1981).</li>
<li>Brinster, R. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Somatic+expression+of+herpes+thymidine+kinase+in+mice+following+injection+of+a+fusion+gene+into+eggs%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs.</a> Cell. 27 (1), 223-231 (1981).</li>
<li>Du, Z., Li, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((RCAS-TVA+in+the+mammary+gland%3A+an+in+vivo+oncogene+screen+and+a+high+fidelity+model+for+breast+transformation%5BTitle%5D)+AND+%22Cell+Cycle%22%5BJournal%5D)">RCAS-TVA in the mammary gland: an in vivo oncogene screen and a high fidelity model for breast transformation.</a> Cell Cycle. 6 (7), 823-826 (2007).</li>
<li>Bu, W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mammary+precancerous+stem+and+non-stem+cells+evolve+into+cancers+of+distinct+subtypes%5BTitle%5D)+AND+%22Cancer+Research%22%5BJournal%5D)">Mammary precancerous stem and non-stem cells evolve into cancers of distinct subtypes.</a> Cancer Research. 79 (1), 61-71 (2019).</li>
<li>Bu, W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Keratin+6a+marks+mammary+bipotential+progenitor+cells+that+can+give+rise+to+a+unique+tumor+model+resembling+human+normal-like+breast+cancer%5BTitle%5D)+AND+%22Oncogene%22%5BJournal%5D)">Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer.</a> Oncogene. 30 (43), 4399-4409 (2011).</li>
<li>Haricharan, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Contribution+of+an+alveolar+cell+of+origin+to+the+high-grade+malignant+phenotype+of+pregnancy-associated+breast+cancer%5BTitle%5D)+AND+%22Oncogene%22%5BJournal%5D)">Contribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancer.</a> Oncogene. 33 (50), 5729-5739 (2014).</li>
<li>Bu, W., Zhang, X., Dai, H., Huang, S., Li, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mammary+cells+with+active+Wnt+signaling+resist+ErbB2-induced+tumorigenesis%5BTitle%5D)+AND+%22PLoS+One%22%5BJournal%5D)">Mammary cells with active Wnt signaling resist ErbB2-induced tumorigenesis.</a> PLoS One. 8 (11), 78720(2013).</li>
<li>Du, Z., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Introduction+of+oncogenes+into+mammary+glands+in+vivo+with+an+avian+retroviral+vector+initiates+and+promotes+carcinogenesis+in+mouse+models%5BTitle%5D)+AND+%22Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America%22%5BJournal%5D)">Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models.</a> Proceedings of the National Academy of Sciences of the United States of America. 103 (46), 17396-17401 (2006).</li>
<li>Siwko, S. K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Lentivirus-mediated+oncogene+introduction+into+mammary+cells+in+vivo+induces+tumors%5BTitle%5D)+AND+%22Neoplasia%22%5BJournal%5D)">Lentivirus-mediated oncogene introduction into mammary cells in vivo induces tumors.</a> Neoplasia. 10 (7), 653-662 (2008).</li>
<li>Bu, W., Xin, L., Toneff, M., Li, L., Li, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Lentivirus+vectors+for+stably+introducing+genes+into+mammary+epithelial+cells+in+vivo%5BTitle%5D)+AND+%22Journal+of+Mammary+Gland+Biology+and+Neoplasia%22%5BJournal%5D)">Lentivirus vectors for stably introducing genes into mammary epithelial cells in vivo.</a> Journal of Mammary Gland Biology and Neoplasia. 14 (4), 401-404 (2009).</li>
<li>Russell, T. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Transduction+of+the+mammary+epithelium+with+adenovirus+vectors+in+vivo%5BTitle%5D)+AND+%22Journal+of+Virology%22%5BJournal%5D)">Transduction of the mammary epithelium with adenovirus vectors in vivo.</a> Journal of Virology. 77 (10), 5801-5809 (2003).</li>
<li>Wagner, S., Thresher, R., Bland, R., Laible, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Adeno-associated-virus-mediated+transduction+of+the+mammary+gland+enables+sustained+production+of+recombinant+proteins+in+milk%5BTitle%5D)+AND+%22Scientific+Reports%22%5BJournal%5D)">Adeno-associated-virus-mediated transduction of the mammary gland enables sustained production of recombinant proteins in milk.</a> Scientific Reports. 5, 15115(2015).</li>
<li>Naldini, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((In+vivo+gene+delivery+and+stable+transduction+of+nondividing+cells+by+a+lentiviral+vector%5BTitle%5D)+AND+%22Science%22%5BJournal%5D)">In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.</a> Science. 272 (5259), 263-267 (1996).</li>
<li>Coffin, J. M., Hughes, S. H., Varmus, H. E. <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=author%3aCoffin%2C+JM+%22Retroviruses%22">Retroviruses</a>. , Cold Spring Harbor Laboratory Press. (1997).</li>
<li>Mitani, K., Kubo, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Adenovirus+as+an+integrating+vector%5BTitle%5D)+AND+%22Current+Gene+Therapy%22%5BJournal%5D)">Adenovirus as an integrating vector.</a> Current Gene Therapy. 2 (2), 135-144 (2002).</li>
<li>McCarty, D. M., Young, S. M., Samulski, R. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Integration+of+adeno-associated+virus+%28AAV%29+and+recombinant+AAV+vectors%5BTitle%5D)+AND+%22Annual+Review+of+Genetics%22%5BJournal%5D)">Integration of adeno-associated virus (AAV) and recombinant AAV vectors.</a> Annual Review of Genetics. 38, 819-845 (2004).</li>
<li>Bu, W., Li, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Intraductal+injection+of+lentivirus+vectors+for+stably+introducing+genes+into+rat+mammary+epithelial+cells+in+vivo%5BTitle%5D)+AND+%22Journal+of+Mammary+Gland+Biology+and+Neoplasia%22%5BJournal%5D)">Intraductal injection of lentivirus vectors for stably introducing genes into rat mammary epithelial cells in vivo.</a> Journal of Mammary Gland Biology and Neoplasia. 25 (4), 389-396 (2020).</li>
<li>Dong, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Genetic+manipulation+of+individual+somatic+mammary+cells+in+vivo+reveals+a+master+role+of+STAT5a+in+inducing+alveolar+fate+commitment+and+lactogenesis+even+in+the+absence+of+ovarian+hormones%5BTitle%5D)+AND+%22Developmental+Biology%22%5BJournal%5D)">Genetic manipulation of individual somatic mammary cells in vivo reveals a master role of STAT5a in inducing alveolar fate commitment and lactogenesis even in the absence of ovarian hormones.</a> Developmental Biology. 346 (2), 196-203 (2010).</li>
<li>Haricharan, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mechanism+and+preclinical+prevention+of+increased+breast+cancer+risk+caused+by+pregnancy%5BTitle%5D)+AND+%22eLife%22%5BJournal%5D)">Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancy.</a> eLife. 2, 00996(2013).</li>
<li>Reddy, J. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Defining+the+ATM-mediated+barrier+to+tumorigenesis+in+somatic+mammary+cells+following+ErbB2+activation%5BTitle%5D)+AND+%22Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America%22%5BJournal%5D)">Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation.</a> Proceedings of the National Academy of Sciences of the United States of America. 107 (8), 3728-3733 (2010).</li>
<li>Dong, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+PR+status+of+the+originating+cell+of+ER%2FPR-negative+mouse+mammary+tumors%5BTitle%5D)+AND+%22Oncogene%22%5BJournal%5D)">The PR status of the originating cell of ER/PR-negative mouse mammary tumors.</a> Oncogene. 35 (31), 4149-4154 (2016).</li>
<li>Young, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Targeting+the+pro-survival+protein+BCL-2+to+prevent+breast+cancer%5BTitle%5D)+AND+%22Cancer+Prevention+Research%22%5BJournal%5D)">Targeting the pro-survival protein BCL-2 to prevent breast cancer.</a> Cancer Prevention Research. 15 (1), 3-10 (2022).</li>
<li>Schlimgen, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Risks+associated+with+lentiviral+vector+exposures+and+prevention+strategies%5BTitle%5D)+AND+%22Journal+of+Occupational+and+Environmental+Medicine%22%5BJournal%5D)">Risks associated with lentiviral vector exposures and prevention strategies.</a> Journal of Occupational and Environmental Medicine. 58 (12), 1159-1166 (2016).</li>
<li>Holloway, K. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Krt6a-positive+mammary+epithelial+progenitors+are+not+at+increased+vulnerability+to+tumorigenesis+initiated+by+ErbB2%5BTitle%5D)+AND+%22PLoS+One%22%5BJournal%5D)">Krt6a-positive mammary epithelial progenitors are not at increased vulnerability to tumorigenesis initiated by ErbB2.</a> PLoS One. 10 (1), 0117239(2015).</li>
<li>Holloway, K. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Targeting+oncogenes+into+a+defined+subset+of+mammary+cells+demonstrates+that+the+initiating+oncogenic+mutation+defines+the+resulting+tumor+phenotype%5BTitle%5D)+AND+%22International+Journal+of+Biological+Sciences%22%5BJournal%5D)">Targeting oncogenes into a defined subset of mammary cells demonstrates that the initiating oncogenic mutation defines the resulting tumor phenotype.</a> International Journal of Biological Sciences. 12 (4), 381-388 (2016).</li>
<li>Hein, S. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Luminal+epithelial+cells+within+the+mammary+gland+can+produce+basal+cells+upon+oncogenic+stress%5BTitle%5D)+AND+%22Oncogene%22%5BJournal%5D)">Luminal epithelial cells within the mammary gland can produce basal cells upon oncogenic stress.</a> Oncogene. 35 (11), 1461-1467 (2015).</li>
<li>Annunziato, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((In+situ+CRISPR-Cas9+base+editing+for+the+development+of+genetically+engineered+mouse+models+of+breast+cancer%5BTitle%5D)+AND+%22EMBO+Journal%22%5BJournal%5D)">In situ CRISPR-Cas9 base editing for the development of genetically engineered mouse models of breast cancer.</a> EMBO Journal. 39 (5), 102169(2020).</li>
<li>Annunziato, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Modeling+invasive+lobular+breast+carcinoma+by+CRISPR%2FCas9-mediated+somatic+genome+editing+of+the+mammary+gland%5BTitle%5D)+AND+%22Genes+%26+Development%22%5BJournal%5D)">Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland.</a> Genes & Development. 30 (12), 1470-1480 (2016).</li>
</ol>

Both the authors declare no conflicts of interest.

This article demonstrates the viral intraductal injection technique for introducing genes into mouse mammary epithelial cells for modeling sporadic breast cancer. Usually, mice of at least 5 weeks or older are injected so that the oncogenic process starts after the mammary gland is developed. Besides, the nipple opening of mice younger than 5 weeks old is often too small for injection. On the other hand, the nipples of very old mice are sometimes degenerated, and transection may fail to reveal a ductal opening. It is als...

Epithelial cells of mammary glands play a major role in the function of these glands and are the major cell of origin of breast cancer. Studies of mammary gland biology and tumorigenesis frequently need the delivery of gene(s) of interest into these cells. Each mouse mammary gland comprises a ductal tree lined by epithelial cells with a single opening at the tip of the nipple. This structure makes the mammary epithelial cells easily accessible to viral vectors, which can be delivered into the lumen of a ductal tree via intraductal injection1.
The technique of mammary intraductal injection was originally used for much larger animals such as goats, rabbits, and rats1. For a much smaller animal such as mice, intraductal injection needs many delicate tools and more practices of the operators. There are two approaches for mouse intraductal injection. One is up-the-teat injection1. Another one is the direct injection of the primary duct of #3 or #4 mammary gland after surgical exposure1. Since the first one is non-invasive and faster once the operator has been well-trained, this technique is more commonly used and will be described in detail in this article.
Compared to the widely used traditional transgenic mouse models, in which the gene of interest is introduced at the stage of fertilized eggs through microinjection2,3,4, gene delivery through the intraductal virus injection method has many advantages, including: (1) it avoids the time-consuming process of making a transgenic mouse line for each gene of interest; (2) it avoids potential impairment on the normal development of mammary glands imposed by the gene of interest; (3) it introduces the gene of interest at any desired time after birth; (4) it can easily co-introduce more than one gene of interest; (5) it better mimics the natural tumorigenic process because the infected and thus oncogene-carrying cells are surrounded by normal cells; and (6) in combination with the TVA (tumor virus A, an avian cell surface protein and the receptor for retrovirus RCAS vector) technology5, the gene of interest can be introduced into a specific cell population to study the cell origin of tumorigenesis and to conduct cell lineage-tracing assays in the mammary glands6,7,8,9.
Any vectors derived from retrovirus10, lentivirus11,12, adenovirus13, and adenovirus-associated virus (AAV)14 may be used for intraductal delivery of genetic materials. Retrovirus and lentivirus vectors integrate into the host genome permanently; thus, they introduce genes of interest stably into mammary epithelial cells. While lentivirus can integrate into the genome of any cell it encounters15, the efficient genomic integration of retrovirus needs the proliferation of the target cells16. The adenoviral and AAV vectors do not integrate into the genome of infected cells and, therefore, only transiently express the gene of interest17,18. This feature can be an advantage when the gene of interest needs to be expressed for only a short amount of time, such as Cre, for deleting a floxed tumor suppressor gene.
Lentivirus, adenovirus, and AAV infect any mouse cells they encounter. But since luminal epithelium is largely insulated from the underlying basal layer, which is further separated from the stroma by the basement membrane, intraductal injection limits the infection largely to luminal epithelial cells, the primary cell of origin of breast cancer. Within this luminal epithelial layer, there are also distinct cell subtypes, including stem cells, progenitor cells, and several groups of differentiated cells. To infect specific cell subsets within the luminal cell population, the TVA technology may be used, with which avian leukosis virus-derived RCAS vectors5,10 or pseudotyped lentiviral vectors11 selectively infect the cells that express TVA in mice that carry a tva transgene under the control of a cell type-specific promoter, such as a promoter that is active only in stem cells6 or certain progenitors6,7 or alveolar cells8 or Wnt-pathway active cells9.
This protocol presents the technique of introducing genes of interest into mammary epithelial cells through intraductal injection of a viral vector. The detection of expression of the introduced genes and the resulting hyperplastic lesions and tumors are then demonstrated.

<table><tbody><tr><td>Anti-HA antibody</td><td>Covance</td><td>MMS-101P</td><td>Dilution: 1 : 1000</td></tr><tr><td>Artificial Tears</td><td>Covetrus</td><td>NDC 11695-0832-1</td><td></td></tr><tr><td>Bromophenol blue</td><td>Sigma</td><td>B5525</td><td>microwave radiation for 45 seconds at power high of 1250W microwave oven</td></tr><tr><td>FACSCantoII</td><td>BD Biosciences</td><td>V96100899</td><td></td></tr><tr><td>Fluorescent stereomicroscope</td><td>Leica</td><td>MZ16 FA</td><td></td></tr><tr><td>FUCGW lenti-virus</td><td>Self-made</td><td>N/A</td><td>See reference # 12</td></tr><tr><td>FVB/N</td><td>The Jackson Laboratory</td><td>JAX:001800</td><td></td></tr><tr><td>Hamilton needle</td><td>Hamilton</td><td>91033</td><td>autoclaved</td></tr><tr><td>Hamilton syringe</td><td>Hamilton</td><td>201000</td><td>autoclaved</td></tr><tr><td>LED magnifying lamp</td><td>Intertek</td><td>3165273</td><td></td></tr><tr><td>Micro dissection spring scissor</td><td>Roboz</td><td>RS-5621</td><td>autoclaved</td></tr><tr><td>MMTV-tva</td><td>Self-made</td><td></td><td>See reference # 10</td></tr><tr><td>RCAS-Neu (HA)</td><td>Self-made</td><td>N/A</td><td>See reference # 10</td></tr><tr><td>Rodent Comboanesthetic III</td><td>Veterinary Pharmacy</td><td>Veterinary prescription</td><td>37.6 mg/mL ketamine, 1.92 mg/mL xylazine, and 0.38 mg/mL acepromazine</td></tr></tbody></table>

in vivo gene delivery into mouse mammary epithelial cells through mammary intraductal injection

In Vivo Gene Delivery into Mouse Mammary Epithelial Cells Through Mammary Intraductal Injection

Mouse mammary glands comprise ductal trees, which are lined by epithelial cells and have one opening at the tip of each nipple. The epithelial cells play a major role in mammary gland function and are the origin of most mammary tumors. Introducing genes of interest into mouse mammary epithelial cells is a critical step in evaluating gene function in epithelial cells and generating mouse mammary tumor models. This goal can be accomplished through the intraductal injection of a viral vector carrying the genes of interest into the mouse mammary ductal tree. The injected virus subsequently infects mammary epithelial cells, bringing in the genes of interest. The viral vector can be lentiviral, retroviral, adenoviral, or adenovirus-associated viral (AAV). This study demonstrates how a gene of interest is delivered into mammary epithelial cells through mouse mammary intraductal injection of a viral vector. A lentivirus carrying GFP is used to show stable expression of a delivered gene, and a retrovirus carrying Erbb2 (HER2/Neu) is used to demonstrate oncogene-induced atypical hyperplastic lesions and mammary tumors.

Representative data are presented here to demonstrate successful intraductal injection, successful viral infection, and the impact of the delivered genes on mammary tumorigenesis. The amount of virus injected must be tailored to the purpose of each experiment. To illustrate how extensively the mammary duct tree can be infected, a large amount of virus carrying genes that can be imaged, such as GFP, needs to be used. On the other hand, to mimic the natural spontaneous tumorigenesis, a small amount of virus carrying an onc...

The present protocol describes intraductal injection of viral vectors via the teat to deliver genes of interest into the mammary epithelial cells.

Mouse mammary glands comprise ductal trees, which are lined by epithelial cells and have one opening at the tip of each nipple. The epithelial cells play ...

in-vivo-gene-delivery-into-mouse-mammary-epithelial-cells-through

Research

JoVE Journal

Cancer Research

This video describes an intraductal injection technique where we deliver injection mix into the ducts of mouse mammary glands.

Intraductal Injection: Delivering Injection Mix into the Ducts of the Mouse Mammary Gland

A protocol for the non-invasive intraductal delivery of aqueous reagents to the mouse mammary gland is described. The method takes advantage of localized injection into the nipples of mammary glands targeting mammary ducts specifically. This technique is adaptable for a variety of compounds including siRNA, chemotherapeutic agents and small molecules.

Intraductal Injection for Localized Drug Delivery to the Mouse Mammary Gland

Activation of latent mutations with adenovirus-Cre into the mammary ductal system results in a clinically relevant metastatic breast cancer. Incorporation of a YFP promoter allows tracking of distal metastatic tumor cells. This model is useful to study latent metastasis, anti-tumor immunity, and for designing novel immunotherapies to treat breast cancer.

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Cancer is a complex disease that is influenced by the tissue surrounding the tumor as well as local pro- and anti-inflammatory mediators. Therefore, orthotropic injection models, rather than subcutaneous models may be useful to study cancer progression in a manner that better mimics human pathology.

Orthotopic Injection of Breast Cancer Cells into the Mammary Fat Pad of Mice to Study Tumor Growth.

Here, we describe a technique for the localized delivery of reagents to the rabbit mammary gland via an intraductal injection. In addition, we describe a protocol for visualization and the confirmation of delivery by high-resolution ultrasound imaging of contrast agents.

Intraductal Delivery to the Rabbit Mammary Gland

Here, we present a protocol to implant breast cancer cells into the mammary fat pad in a simple, less invasive, and easy-to-handle way, and this mouse orthotopic breast cancer model with a proper mammary fat pad environment can be used to investigate various aspects of cancer.

Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad

The goal of this protocol is to describe a new breast cancer modeling approach based on the intraductal injection of Cre-expressing adenovirus into mouse mammary glands. This approach allows both cell-type- and organ-specific manipulation of oncogenic events in a temporally controlled manner.

Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland

A method of intraductal injection of reagents for an ethanol-based ablative solution to the mouse mammary ductal tree for in vivo imaging and breast cancer prevention is described. Injection directly into the nipple opening allows for targeting mammary epithelial cells with minimal collateral tissue damage.

Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models

The present protocol describes a facile technique for the intravital imaging of the lactating mouse mammary gland by laser scanning confocal and multiphoton microscopy.

Intravital Subcellular Microscopy of the Mammary Gland

The manuscript describes a methodology for the establishment as well as longitudinal growth monitoring of spontaneous lung metastasis from orthotopically-injected breast tumors, amenable to intervention at all stages of the metastatic cascade.

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells

This protocol describes a scalable intraductal CRISPR screening approach enabling parallel in vivo gene knockout and activation studies in the mouse mammary gland.

Parallel In Vivo Screening of Gene Knockout and Activation in the Mouse Mammary Gland

Learn intraductal injection of viral vectors for gene delivery into mouse mammary epithelial cells. This method enables controlled genetic manipulation to study tumor genesis and breast cancer biology in vivo.

In Vivo Gene Delivery into Mouse Mammary Epithelial Cells Through Mammary Intraductal Injection

Explore More Videos